Timothée Laloux, PhD, currently serves as an Expert Scientist in Preclinical R&D, specializing in antigen design and production at GSK since June 2021. Previous experience includes a role as a Research Fellow in molecular and cellular biology at F.R.S. - FNRS from October 2014 to September 2019, focusing on interactions between SNAREs, plasma membrane aquaporins, and the potassium channel KC1. Timothée participated in "ma thèse en 180 secondes" at Université catholique de Louvain in early 2018 and completed Erasmus exchange training at Universidad Pablo de Olavide in 2014, where research involved genome editing of zebrafish Iroquois genes using the CRISPR/Cas9 system. Timothée's education includes a Bachelor's degree in Biology, a Master's degree, and a PhD in Biochemistry and Molecular Biology from Université catholique de Louvain, along with exchange programs at Universidad Pablo de Olavide and University College Cork.